XML 63 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
FINANCIAL INSTRUMENTS - Narrative (Details)
$ in Thousands
12 Months Ended
Sep. 20, 2023
USD ($)
shares
Aug. 02, 2023
USD ($)
d
shares
Sep. 20, 2021
USD ($)
shares
Dec. 31, 2023
USD ($)
shares
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Financial Instruments [Line Items]            
Business acquisition, anniversary       5 years    
Issuance of common stock in acquisition       $ 76,642   $ 237,885
Issuance of common stock following milestone achievement (in shares) | shares       8,988,391    
Issuance of common stock following milestone achievement       $ 84,761    
Investment income, net       32,800 $ 9,200  
Omniome, Inc            
Financial Instruments [Line Items]            
Total cash paid $ 100,900   $ 315,703      
Issuance of common stock in acquisition (in shares) | shares 9,000,000   8,911,580      
Issuance of common stock in acquisition $ 95,900          
Milestone revenue       $ 101,300    
Omniome, Inc | Common Stock            
Financial Instruments [Line Items]            
Issuance of common stock in acquisition 100,000          
Omniome, Inc | Employee Stock Option            
Financial Instruments [Line Items]            
Issuance of common stock in acquisition $ 4,100          
Apton            
Financial Instruments [Line Items]            
Total cash paid   $ 200        
Issuance of common stock in acquisition (in shares) | shares   6,121,571   6,300,000    
Average trading period | d   20        
Minimum | Valuation, Income Approach | Measurement Input, Risk Free Interest Rate            
Financial Instruments [Line Items]            
Discount rates       0.078    
Maximum | Valuation, Income Approach | Measurement Input, Risk Free Interest Rate            
Financial Instruments [Line Items]            
Discount rates       0.082